Very-low-dose warfarin reduced thromboembolism in patients with metastatic breast cancer who were receiving chemotherapy

Abstract

TherapeuticsSeptember 1, 1994Very-low-dose warfarin reduced thromboembolism in patients with metastatic breast cancer who were receiving chemotherapyJohn S. Kizer, MDJohn S. Kizer, MDUniversity of North Carolina, Chapel Hill, North Carolina, USA (J.S.K.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-1994-121-2-034 SectionsAboutFull Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinkedInRedditEmail Source CitationLevine M, Hirsh J, Gent M, et al. Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet. 1994 Apr 9;343:886-9. Author, Article, and Disclosure InformationAffiliations: University of North Carolina, Chapel Hill, North Carolina, USA (J.S.K.) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails September 1, 1994Volume 121, Issue 2Page: 34KeywordsAlcoholismAnticoagulant therapyBilirubinBrainBreast cancerCancer chemotherapyCancer preventionCancer treatmentChemotherapyDeep vein thrombosisHemorrhageMood disordersPeptic ulcersPlateletsSafetySurvival analysisThromboembolismThrombosisVenous thromboembolism ePublished: 9 March 2020 Issue Published: September 1, 1994 Copyright & PermissionsCopyright © 1994 by American College of Physicians. All Rights Reserved.Loading ...